Prof Peter Revill
Honorary (Professorial Fellow)
Department of Infectious Diseases
184 Scholarly works
20 Projects
HIGHLIGHTS
2026
Journal article
Corrigendum to “Overview of gene editing strategies against HBV”(Antiviral Research, (2026), 247, C, (106355), (S0166354226000148), 10.1016/j.antiviral.2026.106355)
DOI: 10.1016/j.antiviral.2026.1064882026
Journal article
Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B
DOI: 10.1093/infdis/jiaf5692026
Journal article
Overview of gene editing strategies against HBV
DOI: 10.1016/j.antiviral.2026.1063552026
Journal article
Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection
DOI: 10.1093/cid/ciaf2812022
Research Grant
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
2022
Research grants (other domestic)
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
2022
Internal Research Grant
Developing a Novel RNA Therapeutic for Chronic Hepatitis B
RECENT SCHOLARLY WORKS
2025
Journal article
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV–hepatitis B virus co-infection model system
DOI: 10.1128/spectrum.00809-252024
Journal article
Availability of point-of-care HBV tests in resource-limited settings
DOI: 10.1016/S2468-1253(24)00308-X2024
Journal article
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression
DOI: 10.1016/j.jhep.2024.05.0252024
Conference Proceedings
ANTI- HBS IMMUNE COMPLEX LEVELS: A NOVEL BIOMARKER OF HEPATITIS FLARE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B WHO STOP NUCLEOS( T) IDE ANALOGUE THERAPY
2024
Journal article
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy
DOI: 10.1111/liv.160292024
Conference Proceedings
Anti-HBs immune complex levels: A novel biomarker of hepatitis flare in patients with HBeAg-negative chronic hepatitis B who stop nucleos(t)ide analogue therapy
RECENT PROJECTS
2023
Research Grant
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B
2023
Research Grant
Novel Monoclonal Antibodies to Treat Chronic Hepatitis B